Affomix Corportation

  • Home
  • Technology
    • Y2HExpressTM
    • Phage ESCapeTM
    • mAb Optimization
    • Protein Quantitation
  • Products & Services
    • Overview
    • Current Offering
    • Future Offerings
  • Applications
    • Overview
  • Resources
    • Links
  • News & Events
    • Press Releases
    • In the News
    • Conferences
  • About Us
    • Key Personnel
    • Board of Directors
    • Scientific Advisory Board
    • Careers
    • Collaborations/Partners
    • Contact Us

Affomix has proprietary technology for rapid, automated, high-throughput selection of human monoclonal antibodies.

Press Releases

  • 6/1/2010 - Affomix and The University of Montreal Pharmacogenomics Centre Collaborate on Digital Proteomic Signatures in Pharmacogenomics for Use in Clinical Trials
  • 1/19/2010 - Digital Proteomics On Next Generation Sequencers: Affomix and City of Hope Announce Collaboration
  • 12/29/2009 - Affomix to Provide Antibodies for KalGene Pharmaceutical’s Therapeutic and Companion Diagnostics Program
  • 11/16/2009 - Millipore and Affomix Announce Technology Evaluation Agreement
  • 02/20/2008 - Affomix Corporation Closes $7M Series A Preferred Venture Financing Round

  

© 2009 Affomix

  • Home
  • Technology
  • Products & Services
  • Apps
  • Resources
  • News & Events
  • About Us